Skip to main content
Top
Published in: Journal of NeuroVirology 3/2012

01-06-2012

Cytokine levels in CSF and neuropsychological performance in HIV patients

Authors: Thorsten Nolting, Antje Lindecke, Hans-Peter Hartung, Eleni Koutsilieri, Matthias Maschke, Ingo-W. Husstedt, Sieghart Sopper, Olaf Stüve, Gabriele Arendt, and the German Competence Network HIV/AIDS

Published in: Journal of NeuroVirology | Issue 3/2012

Login to get access

Abstract

HIV-associated dementia and its precursors are frequently observed complications of HIV infection, even in the presence of combination antiretroviral treatment (cART). The development, surveillance and treatment of this condition are still not completely understood. Cytokines, as immunological transmitters, may be one key to gaining a deeper understanding of the disease. A total of 33 HIV-positive male patients were evaluated by neuropsychological testing, lumbar and venous puncture, neuroimaging and neurological examination. The cytokine content in the CSF (cerebrospinal fluid) was examined by a solid-phase protein array. The Digit–Symbol Test, contraction time analysis, Rey–Osterrieth Figure and Grooved-Pegboard Test showed inferior results in the presence of an inflammatory CSF environment, whereas neuroprotective or anti-inflammatory conditions were correlated to better results in contraction time analysis. Higher CSF levels of cytokines were independently correlated with the duration of HIV infection. The study showed a correlation of cytokine levels in the CSF of HIV patients with test results of their neuropsychological functioning. The effect was pronounced with regard to the more complex executive tasks. Determining CSF cytokine levels may be a useful supplement to the assessment of HIV patients and contribute helpful information to predict neurocognitive performance. Therapeutic strategies to ameliorate a negative impact of an altered cytokine milieu may aid in slowing the evolution of neurocognitive dysfunction.
Literature
go back to reference An SF, Giometto B, Groves M, Miller RF, Beckett AA, Gray F, Tavolato B, Scaravilli F (1997) Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 56:1262–1268PubMedCrossRef An SF, Giometto B, Groves M, Miller RF, Beckett AA, Gray F, Tavolato B, Scaravilli F (1997) Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 56:1262–1268PubMedCrossRef
go back to reference Ances BM, Ellis RJ (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27:86–92PubMedCrossRef Ances BM, Ellis RJ (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 27:86–92PubMedCrossRef
go back to reference Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799PubMedCrossRef Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799PubMedCrossRef
go back to reference Arendt G, Nolting T, Frisch C, Husstedt IW, Gregor N, Koutsilieri E, Maschke M, Angerer A, Obermann M, Neuen-Jacob E, Adams O, Loeffert S, Riederer P, ter Meulen V, Sopper S (2007) Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease. J Neurovirol 13:225–232PubMedCrossRef Arendt G, Nolting T, Frisch C, Husstedt IW, Gregor N, Koutsilieri E, Maschke M, Angerer A, Obermann M, Neuen-Jacob E, Adams O, Loeffert S, Riederer P, ter Meulen V, Sopper S (2007) Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease. J Neurovirol 13:225–232PubMedCrossRef
go back to reference Binder GK, Griffin DE (2003) Immune-mediated clearance of virus from the central nervous system. Microbes Infect 5:439–448PubMedCrossRef Binder GK, Griffin DE (2003) Immune-mediated clearance of virus from the central nervous system. Microbes Infect 5:439–448PubMedCrossRef
go back to reference Capuron L, Pagnoni G, Demetrashvili M, Woolwine BJ, Nemeroff CB, Berns GS, Miller AH (2005) Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry 58:190–196PubMedCrossRef Capuron L, Pagnoni G, Demetrashvili M, Woolwine BJ, Nemeroff CB, Berns GS, Miller AH (2005) Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry 58:190–196PubMedCrossRef
go back to reference Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR, Kauwe JS (2009) CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73:1982–1987PubMedCrossRef Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR, Kauwe JS (2009) CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73:1982–1987PubMedCrossRef
go back to reference Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446–457PubMedCrossRef Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67:446–457PubMedCrossRef
go back to reference Gannon P, Khan MZ, Kolson DL (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 24:275–283PubMedCrossRef Gannon P, Khan MZ, Kolson DL (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 24:275–283PubMedCrossRef
go back to reference Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, Tavolato B, Beckett AA, Scaravilli F (1997) Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol 42:34–40PubMedCrossRef Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, Tavolato B, Beckett AA, Scaravilli F (1997) Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol 42:34–40PubMedCrossRef
go back to reference Giunta B, Obregon D, Hou H, Zeng J, Sun N, Nikolic V, Ehrhart J, Shytle D, Fernandez F, Tan J (2006) EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia. Brain Res 1123:216–225PubMedCrossRef Giunta B, Obregon D, Hou H, Zeng J, Sun N, Nikolic V, Ehrhart J, Shytle D, Fernandez F, Tan J (2006) EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia. Brain Res 1123:216–225PubMedCrossRef
go back to reference Grovit-Ferbas K, Harris-White ME (2010) Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction. Immunol Res 48:40–58PubMedCrossRef Grovit-Ferbas K, Harris-White ME (2010) Thinking about HIV: the intersection of virus, neuroinflammation and cognitive dysfunction. Immunol Res 48:40–58PubMedCrossRef
go back to reference Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D, Perry VH (2003) Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 74:788–789PubMedCrossRef Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D, Perry VH (2003) Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 74:788–789PubMedCrossRef
go back to reference Kerr D, Krishnan C, Pucak ML, Carmen J (2005) The immune system and neuropsychiatric diseases. Int Rev Psychiatry 17:443–449PubMedCrossRef Kerr D, Krishnan C, Pucak ML, Carmen J (2005) The immune system and neuropsychiatric diseases. Int Rev Psychiatry 17:443–449PubMedCrossRef
go back to reference Kipnis J, Derecki NC, Yang C, Scrable H (2008) Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common? Trends Immunol 29:455–463PubMedCrossRef Kipnis J, Derecki NC, Yang C, Scrable H (2008) Immunity and cognition: what do age-related dementia, HIV-dementia and 'chemo-brain' have in common? Trends Immunol 29:455–463PubMedCrossRef
go back to reference Kraft-Terry SD, Buch SJ, Fox HS, Gendelman HE (2009) A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron 64:133–145PubMedCrossRef Kraft-Terry SD, Buch SJ, Fox HS, Gendelman HE (2009) A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron 64:133–145PubMedCrossRef
go back to reference Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD (1998) Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis Assoc Disord 12:215–227PubMedCrossRef Lanzrein AS, Johnston CM, Perry VH, Jobst KA, King EM, Smith AD (1998) Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis Assoc Disord 12:215–227PubMedCrossRef
go back to reference Laspiur JP, Anderson ER, Ciborowski P, Wojna V, Rozek W, Duan F, Mayo R, Rodriguez E, Plaud-Valentin M, Rodriguez-Orengo J, Gendelman HE, Melendez LM (2007) CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol 192:157–170PubMedCrossRef Laspiur JP, Anderson ER, Ciborowski P, Wojna V, Rozek W, Duan F, Mayo R, Rodriguez E, Plaud-Valentin M, Rodriguez-Orengo J, Gendelman HE, Melendez LM (2007) CSF proteomic fingerprints for HIV-associated cognitive impairment. J Neuroimmunol 192:157–170PubMedCrossRef
go back to reference Letendre SL, Zheng JC, Kaul M, Yiannoutsos CT, Ellis RJ, Taylor MJ, Marquie-Beck J, Navia B (2011) Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals. J Neurovirol 17:63–69PubMedCrossRef Letendre SL, Zheng JC, Kaul M, Yiannoutsos CT, Ellis RJ, Taylor MJ, Marquie-Beck J, Navia B (2011) Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals. J Neurovirol 17:63–69PubMedCrossRef
go back to reference McArthur JC, Brew BJ, Nath A (2005) Neurological complications of HIV infection. Lancet Neurol 4:543–555PubMedCrossRef McArthur JC, Brew BJ, Nath A (2005) Neurological complications of HIV infection. Lancet Neurol 4:543–555PubMedCrossRef
go back to reference McArthur JC, Steiner J, Sacktor N, Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 67:699–714PubMedCrossRef McArthur JC, Steiner J, Sacktor N, Nath A (2010) Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 67:699–714PubMedCrossRef
go back to reference Miller AH, Pariante CM, Pearce BD (1999) Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv Exp Med Biol 461:107–116PubMedCrossRef Miller AH, Pariante CM, Pearce BD (1999) Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv Exp Med Biol 461:107–116PubMedCrossRef
go back to reference Moore DJ, Letendre SL, Morris S, Umlauf A, Deutsch R, Smith DM, Little S, Rooney A, Franklin DR, Gouaux B, Leblanc S, Rosario D, Fennema-Notestine C, Heaton RK, Ellis RJ, Atkinson JH, Grant I (2011) Neurocognitive functioning in acute or early HIV infection. J Neurovirol 17:50–57PubMedCrossRef Moore DJ, Letendre SL, Morris S, Umlauf A, Deutsch R, Smith DM, Little S, Rooney A, Franklin DR, Gouaux B, Leblanc S, Rosario D, Fennema-Notestine C, Heaton RK, Ellis RJ, Atkinson JH, Grant I (2011) Neurocognitive functioning in acute or early HIV infection. J Neurovirol 17:50–57PubMedCrossRef
go back to reference Nolting T, Lindecke A, Koutsilieri E, Maschke M, Husstedt IW, Sopper S, Stuve O, Hartung HP, Arendt G (2009) Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus-positive patients at distinct stages of infection by solid-phase protein array. J Neurovirol 15:390–400PubMedCrossRef Nolting T, Lindecke A, Koutsilieri E, Maschke M, Husstedt IW, Sopper S, Stuve O, Hartung HP, Arendt G (2009) Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus-positive patients at distinct stages of infection by solid-phase protein array. J Neurovirol 15:390–400PubMedCrossRef
go back to reference Patarca-Montero R, Antoni M, Fletcher MA, Klimas NG (2001) Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol 8:51–64PubMedCrossRef Patarca-Montero R, Antoni M, Fletcher MA, Klimas NG (2001) Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol 8:51–64PubMedCrossRef
go back to reference Pellegrini P, Berghella AM, Di Loreto S, Del Beato T, Di Marco F, Adorno D, Casciani CU (1996) Cytokine contribution to the repair processes and homeostasis recovery following anoxic insult: a possible IFN-gamma-regulating role in IL-1beta neurotoxic action in physiological or damaged CNS. Neuroimmunomodulation 3:213–218PubMedCrossRef Pellegrini P, Berghella AM, Di Loreto S, Del Beato T, Di Marco F, Adorno D, Casciani CU (1996) Cytokine contribution to the repair processes and homeostasis recovery following anoxic insult: a possible IFN-gamma-regulating role in IL-1beta neurotoxic action in physiological or damaged CNS. Neuroimmunomodulation 3:213–218PubMedCrossRef
go back to reference Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–452PubMedCrossRef Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–452PubMedCrossRef
go back to reference Rempel JD, Quina LA, Blakely-Gonzales PK, Buchmeier MJ, Gruol DL (2005) Viral induction of central nervous system innate immune responses. J Virol 79:4369–4381PubMedCrossRef Rempel JD, Quina LA, Blakely-Gonzales PK, Buchmeier MJ, Gruol DL (2005) Viral induction of central nervous system innate immune responses. J Virol 79:4369–4381PubMedCrossRef
go back to reference Tomonaga K (2004) Virus-induced neurobehavioral disorders: mechanisms and implications. Trends Mol Med 10:71–77PubMedCrossRef Tomonaga K (2004) Virus-induced neurobehavioral disorders: mechanisms and implications. Trends Mol Med 10:71–77PubMedCrossRef
go back to reference Velazquez I, Plaud M, Wojna V, Skolasky R, Laspiur JP, Melendez LM (2009) Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment. J Neuroimmunol 206:106–111PubMedCrossRef Velazquez I, Plaud M, Wojna V, Skolasky R, Laspiur JP, Melendez LM (2009) Antioxidant enzyme dysfunction in monocytes and CSF of Hispanic women with HIV-associated cognitive impairment. J Neuroimmunol 206:106–111PubMedCrossRef
go back to reference Vollmer-Conna U, Fazou C, Cameron B, Li H, Brennan C, Luck L, Davenport T, Wakefield D, Hickie I, Lloyd A (2004) Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 34:1289–1297PubMedCrossRef Vollmer-Conna U, Fazou C, Cameron B, Li H, Brennan C, Luck L, Davenport T, Wakefield D, Hickie I, Lloyd A (2004) Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 34:1289–1297PubMedCrossRef
go back to reference Wichers MC, Kenis G, Leue C, Koek G, Robaeys G, Maes M (2006) Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment. Biol Psychiatry 60:77–79PubMedCrossRef Wichers MC, Kenis G, Leue C, Koek G, Robaeys G, Maes M (2006) Baseline immune activation as a risk factor for the onset of depression during interferon-alpha treatment. Biol Psychiatry 60:77–79PubMedCrossRef
go back to reference Wildemann B, Ehrhart K, Storch-Hagenlocher B, Meyding-Lamade U, Steinvorth S, Hacke W, Haas J (1997) Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology 48:1341–1346PubMedCrossRef Wildemann B, Ehrhart K, Storch-Hagenlocher B, Meyding-Lamade U, Steinvorth S, Hacke W, Haas J (1997) Quantitation of herpes simplex virus type 1 DNA in cells of cerebrospinal fluid of patients with herpes simplex virus encephalitis. Neurology 48:1341–1346PubMedCrossRef
go back to reference Zhu CB, Blakely RD, Hewlett WA (2006) The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31:2121–2131PubMed Zhu CB, Blakely RD, Hewlett WA (2006) The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31:2121–2131PubMed
Metadata
Title
Cytokine levels in CSF and neuropsychological performance in HIV patients
Authors
Thorsten Nolting
Antje Lindecke
Hans-Peter Hartung
Eleni Koutsilieri
Matthias Maschke
Ingo-W. Husstedt
Sieghart Sopper
Olaf Stüve
Gabriele Arendt
and the German Competence Network HIV/AIDS
Publication date
01-06-2012
Publisher
Springer US
Published in
Journal of NeuroVirology / Issue 3/2012
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-012-0091-4

Other articles of this Issue 3/2012

Journal of NeuroVirology 3/2012 Go to the issue